Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|July 13, 2019
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocolRenato Bassan, Monica Fumagalli, Sabina Chiaretti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00Renato Bassan, Giuseppe Rossi, Enrico M Pogliani, et al.
Haematologica|October 19, 2010
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphomaNicola Gökbuget, Christina-Maria Hartog, Renato Bassan, et al.
Haematologica|November 8, 2011
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual diseaseFrancesco Mannelli, Giacomo Gianfaldoni, Tamara Intermesoli, et al.
The New England Journal of Medicine|October 21, 2020
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in AdultsRobin Foà, Renato Bassan, Antonella Vitale, et al.
Blood Cancer Journal|November 14, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07Renato Bassan, Chiara Pavoni, Tamara Intermesoli, et al.
Expert Opinion on Biological Therapy|May 17, 2017
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?Francesca Patriarca, Luisa Giaccone, Francesco Onida, et al.
The Journal of Molecular Diagnostics : JMD|June 16, 2022
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic LeukemiaIrene Della Starza, Lucia A De Novi, Alessandra Santoro, et al.
Haematologica|March 10, 2015
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemiaRenato Bassan, Arianna Masciulli, Tamara Intermesoli, et al.
Haematologica|March 3, 2017
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological featuresFrancesco Mannelli, Vanessa Ponziani, Sara Bencini, et al.
Pageof 8